Clinical Trial Update: Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Pancreatic Ductal Adenocarcinoma (PDAC) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating 18F-FAPI PET imaging to detect metastatic disease in pancreatic ductal adenocarcinoma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Snippet

Sponsor: SOFIE | Conditions: Pancreatic Ductal Adenocarcinoma (PDAC) | Phase 3 | Status: RECRUITING